G12V RAS TCR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for G12V RAS TCR-T cell therapy, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]